Acadian Asset Management LLC Lowers Stock Position in Personalis, Inc. $PSNL

Key Points

• Acadian Asset Management LLC sold 105,384 shares of Personalis, Inc., reducing its stake by 25.3% to 310,522 shares, valued at approximately $1,087,000.
• Despite the sale, several other institutional investors increased their positions in Personalis, with Royal Bank of Canada and Ameriprise Financial Inc. lifting their stakes by 3.2% and 38.3%, respectively, in the first quarter.
• Personalis's stock traded up 1.6% to $5.82 recently, while the company faces challenges, reporting a negative EPS and lower-than-expected quarterly revenue.

Acadian Asset Management LLC cut its holdings in Personalis, Inc. (NASDAQ:PSNL - Free Report) by 25.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 310,522 shares of the company's stock after selling 105,384 shares during the period. Acadian Asset Management LLC owned about 0.35% of Personalis worth $1,087,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of PSNL. Aberdeen Group plc raised its stake in Personalis by 472.3% in the first quarter. Aberdeen Group plc now owns 1,704,784 shares of the company's stock valued at $5,984,000 after buying an additional 1,406,895 shares in the last quarter. ARK Investment Management LLC increased its position in shares of Personalis by 6.1% during the first quarter. ARK Investment Management LLC now owns 7,188,197 shares of the company's stock worth $25,231,000 after purchasing an additional 412,762 shares in the last quarter. AIGH Capital Management LLC increased its position in shares of Personalis by 4.5% during the first quarter. AIGH Capital Management LLC now owns 3,968,948 shares of the company's stock worth $13,931,000 after purchasing an additional 169,884 shares in the last quarter. Williams Jones Wealth Management LLC. increased its position in shares of Personalis by 765.0% during the fourth quarter. Williams Jones Wealth Management LLC. now owns 134,072 shares of the company's stock worth $775,000 after purchasing an additional 118,572 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its position in shares of Personalis by 55.7% during the first quarter. Goldman Sachs Group Inc. now owns 284,426 shares of the company's stock worth $998,000 after purchasing an additional 101,706 shares in the last quarter. 61.91% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. HC Wainwright reiterated a "buy" rating and set a $8.50 target price on shares of Personalis in a research report on Monday, September 8th. BTIG Research set a $6.00 target price on Personalis in a research report on Wednesday, August 6th. Finally, Wall Street Zen upgraded Personalis from a "sell" rating to a "hold" rating in a research report on Saturday. Five analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $7.42.

Personalis Trading Up 4.8%

Shares of NASDAQ PSNL traded up $0.28 during midday trading on Friday, reaching $6.10. 1,454,507 shares of the company were exchanged, compared to its average volume of 820,663. Personalis, Inc. has a 1 year low of $2.83 and a 1 year high of $7.79. The stock has a fifty day simple moving average of $5.41 and a 200 day simple moving average of $4.93. The stock has a market cap of $540.93 million, a P/E ratio of -4.77 and a beta of 1.76.

Personalis (NASDAQ:PSNL - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.25) by $0.02. Personalis had a negative return on equity of 47.57% and a negative net margin of 113.70%.The firm had revenue of $17.20 million for the quarter, compared to analyst estimates of $20.12 million. Personalis has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, analysts forecast that Personalis, Inc. will post -1.4 earnings per share for the current year.

About Personalis

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.